Furthermore, LRP5 regulates the lung microvasculature via angiopoietin-Tie 2 pathway modulation, indicating that LRP5 is a potentially effective therapeutic target in pulmonary hypertension [42]. Here, LRP5 is linked to pulmonary hypertension.